
price close busi april
intuit surgic manufactur da vinci robot system
use wide rang minimally-invass surgic
biomed devic servic
posit trend maintain posit
strong start
bottom line firm continu produc best-in-class result large-cap med-tech
knock park procedur volum system placement
gm om ep handili eclips expect recommend short-
term investor buy print see preview commentari exit
print re-establish postur maintain core posit large-cap growth
stalwart valuat primari bugaboo competit albeit seemingli
least year away linger concern we/investor pay attent
jnj/verb expect updat market develop
next month
procedur volum side firm continu believ davinci robot system
remain earli inning penetr larg hernia repair market gener
surgeri overal repres firm largest procedur volum bucket wit
total procedur growth overal us ou guidanc rais
vs previous system placement strength y/i stood
print ultim procedur growth remain key focu investor
procedur volum growth histor lead indic addit
system placement sum exit quarter see similar posit near-term
setup stock enter print firm us busi continu
fire cylind evid saw sage last weekend
think continu play ou busi grow remain
upsid call option view wait new quota china uptak vi --
vi reimburs new indic japan anyth thought manag
commentari around japan lean posit follow recent new procedur
reimburs went effect april robot reimburs price in-
line lap although expect opportun play long-term
meaning competit come eventu time see strong runway
system growth expect procedur volum growth remain strong
time intuit owe current valuat ep estim
recommend investor maintain posit current level
throughout continu overal procedur growth
geograph basi us procedur volum grew quarter ou procedur
neg impact fewer oper day vs specif
on-going strength us hernia colorect continu drive domest procedur
volum growth uptak bariatr well gener surgeri
procedur acceler quarter isrg matur procedur categori dvp
dvh continu exceed expect firm expect moder
growth go-forward basi regard hernia opportun us manag
continu view signific potenti adopt ramp inguin
procedur serv primari hernia growth driver date continu pg
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
procedur volum growth remain robust continu check sage see
note highlight strong ramp physician interest robot
util even case definit outcom cost/benefit analys
may proffer strong argument hernia repair current act
lead procedur gener surgeri drive procedur pull across
ou market dynam continu await new system quota china
current system util near capac drive meaning moder
procedur growth quarter sale new system region remain
hold pend govern issuanc new quota firm provid
new updat around time expect new quota base prior
multipl month meaning procedur volum inflect like
quarter minimum view wed note firm upwardli
revis guidanc rang continu moder procedur volum china
factor high end rang japan receiv posit
decis januari mhlw recommend procedur
reimburs procedur approv reimburs effect april
reimburs in-lin laparoscop reimburs level compani
continu expect modest system expans region beyond
current system market given signific system capac
procedur ramp expect gradual physician go train
build experi new procedur categori
guidanc updat base procedur volum strength seen
manag rais bottom end procedur volum growth
guidanc anticip full year growth rang vs prior
rang reiter expect full year gm rang
margin expect step modestli level
balanc year firm feel impact cost associ new
product manag addit reiter expect pro forma
opex growth rang level firm project
incom tax rate rang low end prior
figur intuit surgic result vs cg estim consensu project
hold unchang target price april
biomed devic servic
deriv price target appli ratio line large-
cap med-tech comp group ep model forward ep
compound-annual-growth-rate thu aforement target multipl drive target price-to-earnings
appli pro forma ep estim deriv
target
hold unchang target price april
biomed devic servic
p/e/g valuat financi metric use mean large-cap medic devic price-to-earnings multipl ep pro forma price-to-earnings multipl use group forma year-end figur incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
hold unchang target price april
biomed devic servic
million except per share total servic total gross total oper oper incom expens pre-tax incom tax expens tax incom share ep pro-forma calcul xi trade-in base compens intang liabil litig invest net forma ex tax analysisduct adjust sbc ia margin pro margin includ margin pro incom cont figur revenu model
hold unchang target price april
biomed devic servic
total instrument/access total servic total revenu growth modelgrowth rate assumptionsu system unit sale replacements/trad instal base us intern total total sold ex-oper asp leas total asp per oper modelgrowth rate procedur growth procedur growth procedur growth gener ou urolog gener gynecolog us ww procedur asp revenue/instal system intuit surgic
